Literature DB >> 12297155

Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation.

Erdal Kan1, Ulkü Undeğer, Musa Bali, Nurşen Başaran.   

Abstract

Although the role of reactive oxygen species (ROS) in chronic renal failure (CRF) is not definitely demonstrated, a consistent number of observations has provided evidence for the presence of oxidative stress in uremic patients undergoing maintenance dialysis. In order to investigate this hypothesis further and to understand the role of antioxidant supplementation, peripheral blood lymphocytes were taken from 36 dialysis patients before and after Vitamin E supplementation in a dosage of 600 mg per day (2x300 mg) for 14 weeks and examined in the alkaline Comet assay for DNA strand breakage. The results were also compared with those of 36 controls with comparable age, sex, and smoking habits, and with no history of renal disease. The DNA breakage observed in the lymphocytes of patients before Vitamin E supplementation was significantly higher than in the controls (P<0.001) but a clear protective effect of Vitamin E supplementation were observed after 14 weeks of therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297155     DOI: 10.1016/s1383-5718(02)00205-x

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

Review 1.  Waste anesthetic gas exposure and strategies for solution.

Authors:  Hai-Bo Deng; Feng-Xian Li; Ye-Hua Cai; Shi-Yuan Xu
Journal:  J Anesth       Date:  2018-02-05       Impact factor: 2.078

Review 2.  Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.

Authors:  Zeba Khan; Manoj Pandey; Ravindra M Samartha
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

3.  Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients.

Authors:  Nicole Schupp; Eva Maria Dette; Ursula Schmid; Udo Bahner; Michaela Winkler; August Heidland; Helga Stopper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-29       Impact factor: 3.000

4.  Oxidative DNA damage and activation of c-Jun N-terminal kinase pathway in fibroblasts from patients with hereditary spastic paraplegia.

Authors:  Andreina Milano; Nicola Montesano Gesualdi; Raffaele Teperino; Franca Esposito; Sergio Cocozza; Paola Ungaro
Journal:  Cell Mol Neurobiol       Date:  2005-12       Impact factor: 4.231

Review 5.  Genomic damage in endstage renal disease-contribution of uremic toxins.

Authors:  Nicole Schupp; August Heidland; Helga Stopper
Journal:  Toxins (Basel)       Date:  2010-10-11       Impact factor: 4.546

6.  The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study.

Authors:  Bronislaw A Zachara; Jolanta Gromadzinska; Jadwiga Palus; Zbigniew Zbrog; Rafal Swiech; Ewa Twardowska; Wojciech Wasowicz
Journal:  Biol Trace Elem Res       Date:  2010-07-27       Impact factor: 3.738

7.  Using the cytokinesis-block micronucleus cytome assay to evaluate chromosomal DNA damage in chronic renal patients undergoing bicarbonate haemodialysis and haemodiafiltration.

Authors:  M Guido; A Zizza; M R Tumolo; G Stefanelli; M D'Alba; A Idolo; F Bagordo; F Serio; T Grassi; A DE Donno
Journal:  J Prev Med Hyg       Date:  2016-09

8.  Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.

Authors:  Angélica Rangel-López; Maria Eugenia Paniagua-Medina; Marcia Urbán-Reyes; Martha Cortes-Arredondo; Cleto Alvarez-Aguilar; Joel López-Meza; Alejandra Ochoa-Zarzosa; Bengt Lindholm; Elvia García-López; José Ramón Paniagua
Journal:  Mutagenesis       Date:  2013-03       Impact factor: 3.000

Review 9.  DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers.

Authors:  Nicole Schupp; Helga Stopper; August Heidland
Journal:  Oxid Med Cell Longev       Date:  2016-05-25       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.